KMT2A and leukemia: In this study, we performed an in vivo pooled CRISPR screen that targeted selected cell surface genes that are upregulated in murine MLL-AF9 (KMT2A-MLLT3) LSC-enriched cells and identified CXCR4 as the top regulator of leukemia-initiating cells.